摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methyl-2-(9H-xanthen-9-yl)ethanamine | 55286-76-5

中文名称
——
中文别名
——
英文名称
N-methyl-2-(9H-xanthen-9-yl)ethanamine
英文别名
——
N-methyl-2-(9H-xanthen-9-yl)ethanamine化学式
CAS
55286-76-5
化学式
C16H17NO
mdl
——
分子量
239.317
InChiKey
IJHNXCDKYZEINW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-methyl-2-(9H-xanthen-9-yl)ethanamine1-[4-(3,4-Difluorophenyl)piperazin-1-yl]prop-2-en-1-one乙酸乙酯 为溶剂, 反应 20.0h, 以86%的产率得到C29H31F2N3O2
    参考文献:
    名称:
    Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists
    摘要:
    Structural simplification of the core moieties of obeline and ergoline somatostatin sst(1) receptor antagonists, followed by systematic optimization, led to the identification of novel, highly potent and selective sst(1) receptor antagonists. These achiral, non-peptidic compounds are easily prepared and show promising PK properties in rodents. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.01.072
  • 作为产物:
    描述:
    N-methyl-2-(9H-xanthen-9-yl)acetamide红铝 作用下, 以 甲苯 为溶剂, 反应 3.0h, 以86%的产率得到N-methyl-2-(9H-xanthen-9-yl)ethanamine
    参考文献:
    名称:
    Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists
    摘要:
    Structural simplification of the core moieties of obeline and ergoline somatostatin sst(1) receptor antagonists, followed by systematic optimization, led to the identification of novel, highly potent and selective sst(1) receptor antagonists. These achiral, non-peptidic compounds are easily prepared and show promising PK properties in rodents. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.01.072
点击查看最新优质反应信息

文献信息

  • Piperazine derivatives having sst1 antagonistic activity
    申请人:Troxler J. Thomas
    公开号:US20060079527A1
    公开(公告)日:2006-04-13
    The invention provides compounds of formula (I), wherein X, R 1 and R 2 are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals.
    该发明提供了公式(I)的化合物,其中X,R1和R2如描述中所定义,并提供其制备方法。公式(I)的化合物可用作药物。
  • PIPERAZINE DERIVATIVES HAVING SST1 ANTAGONISTIC ACTIVITY
    申请人:Novartis AG
    公开号:EP1446399B1
    公开(公告)日:2005-05-04
  • US3944566A
    申请人:——
    公开号:US3944566A
    公开(公告)日:1976-03-16
  • US7271168B2
    申请人:——
    公开号:US7271168B2
    公开(公告)日:2007-09-18
  • [EN] PIPERAZINE DERIVATIVES HAVING SST1 ANTAGONISTIC ACTIVITY<br/>[FR] DERIVES DE PIPERAZINE AYANT UNE ACTIVITE ANTAGONISTE SST1
    申请人:NOVARTIS AG
    公开号:WO2003040125A1
    公开(公告)日:2003-05-15
    The invention provides compounds of formula (I), wherein X, R1 and R2 are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals.
查看更多